Home > Insider Trading > Filing (0000899243-17-018338)

Filing Details

Accession Number:: 0000899243-17-018338
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-07-17 17:48:16
Reporting Period:: 2017-07-13

Filing Date:: 2017-07-17
Accepted Time:: 2017-07-17 17:48:16
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1594864	Juno Therapeutics Inc.	JUNO	()	4

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1281933	K Douglas Bratton	201 Main Street, Suite 1900 Fort Worth TX 76102	No	No	Yes	No
1536054	Crestline Management, Lp	201 Main Street, Suite 1900 Fort Worth TX 76102	No	No	Yes	No
1626595	Cl Alaska, L.p.	201 Main Street, Suite 1900 Fort Worth TX 76102	No	No	Yes	No
1626596	Crestline Investors, Inc.	201 Main Street, Suite 1900 Fort Worth TX 76102	No	No	Yes	No
1626597	Crestline Si (Gp), L.p.	201 Main Street, Suite 1900 Fort Worth TX 76102	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2017-07-13	8,000,000	$27.00	9,166,130	No	4	S	Indirect	By CL Alaska, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By CL Alaska, L.P.

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	182,669	Indirect	By JT Line Partners LP

Footnotes

The purchase reported in Column 4 occurred in a block transaction at a price of $27.00 per share.
These 9,166,130 shares of the Issuer are held directly by CL Alaska, L.P. ("CLA"). The general partner of CLA is Crestline SI (GP), L.P. ("Crestline SI") and the investment manager of CLA is Crestline Management, L.P. ("Crestline Management"). Crestline Investors, Inc. ("Crestline") is the general partner of both Crestline SI and Crestline Management. Douglas K. Bratton is the sole director of Crestline. CLA is ultimately controlled by Mr. Bratton and Mr. Bratton has voting and investment power over all of these shares of the Issuer as well as a partial pecuniary interest in the shares held by CLA. Mr. Bratton does not intend to sell additional shares of the Issuer from CLA at this time, however, please see the related disclosures in Item 4 of the Schedule 13D/A filed on June 25, 2015.
(Continued from footnote 2) CLA may be deemed to directly beneficially own all of these shares of the Issuer. Crestline SI, Crestline Management, Crestline and Mr. Bratton may each be deemed to indirectly beneficially own all of these shares of the Issuer. Each such entity and Mr. Bratton disclaims beneficial ownership of these shares, except to the extent of its or his respective pecuniary interest therein.
The shares of the Issuer reported in Column 5 are held directly by JT Line Partners LP ("JT"). The general partner of JT is Bratton Capital Management L.P. ("Bratton Capital Management"). The general partner of Bratton Capital Management is Bratton Capital, Inc. ("Bratton Capital"). Douglas K. Bratton is the sole director of Bratton Capital. JT is ultimately controlled by Mr. Bratton and Mr. Bratton has voting and investment power over all of the shares of the Issuer held by JT, as well as a partial pecuniary interest in such shares. JT directly beneficially owns these shares of the Issuer. Bratton Capital Management, Bratton Capital and Mr. Bratton may each be deemed to indirectly beneficially own the shares of the Issuer held by JT. Each such entity and Mr. Bratton disclaims beneficial ownership of these shares, except to the extent of its or his respective pecuniary interest therein.